Prof Dr. Birgit Lorenz|Ophthalmologie| Best Paper Award

Published on by Top Pharmaceutical

Prof Dr. Birgit Lorenz |Ophthalmologie|Best Paper Award|

Prof Dr. Birgit Lorenz at TransMIT Center of Translational Ophthalmology c/o Justus-Liebig, Germany

PROFILE  

scopus

Orcid

 

Early Academic Pursuits 🎓

Prof. Dr. med. Birgit Lorenz began her distinguished academic journey at the Ludwig-Maximilians-University in Munich, Germany. Her medical studies spanned from 1968 to 1974, with an enriching stint at the Sorbonne/Hôpital Cochin in Paris, France. Demonstrating academic excellence early on, she earned her MD thesis with the highest honors, summa cum laude, in Biochemistry from Ludwig-Maximilians-University in 1974. This solid foundation set the stage for a prolific career in ophthalmology and medical genetics.

Following her graduation, Prof. Lorenz pursued a residency in ophthalmology at the Department of Ophthalmology at Ludwig-Maximilians-University Munich, completing it between 1977 and 1982. During this time, she not only honed her clinical skills but also deepened her commitment to research, eventually leading to a PhD thesis (Habilitation) from the same institution in 1989. Her early academic endeavors also included a prestigious research fellowship at the Institute of Ophthalmology in London, where she worked with renowned institutions like Moorfields Eye Hospital and the Hospital for Sick Children.

Professional Endeavors 🏥

Prof. Lorenz’s professional career is marked by a series of significant appointments at prestigious institutions. Her journey began as a Fellow and Consultant in Ophthalmology at Ludwig-Maximilians-University Munich (1982-1991), where she built a reputation as a dedicated clinician and researcher. In 1991, she transitioned to the University of Regensburg, where she served as a Full Professor of Pediatric Ophthalmology, Strabismology, and Ophthalmic Genetics. Her tenure at Regensburg lasted until 2007, during which time she also led the Department of Pediatric Ophthalmology.

In 2007, Prof. Lorenz moved to Justus-Liebig University Giessen, taking on the role of Full Professor and Chairman of the Department of Ophthalmology. For over a decade, she spearheaded advancements in ophthalmic genetics and pediatric ophthalmology. Even after her official retirement, she continued her impactful work as a Professor Emeritus and Senior Clinical Expert for Inherited Retinal Degenerations at the University of Bonn (2020-2022). Currently, she directs the TransMIT Centre for Translational Ophthalmology at TransMIT GmbH, affiliated with Justus-Liebig-University Giessen.

Contributions and Research Focus 🔬

Throughout her illustrious career, Prof. Lorenz has made profound contributions to the fields of ophthalmic genetics, pediatric ophthalmology, and retinal degenerations. Her research has often focused on inherited retinal diseases (IRDs), with an emphasis on understanding their molecular underpinnings and developing potential gene therapies. A prime example of her work includes her involvement in a significant DFG-funded project on chromatic pupillometry, aimed at creating new biomarkers to quantify retinal function and assess the efficacy of gene therapies.

Prof. Lorenz has also been instrumental in several other groundbreaking projects, such as developing device-independent algorithms for enhanced optical coherence tomography (OCT) in retinal diseases and quantifying rod-and-cone function in X-linked retinal dystrophies. Her research has consistently been at the forefront of efforts to translate scientific discoveries into clinical applications, particularly in the realm of gene and cell-based therapies for neuroretinal degeneration.

Accolades and Recognition 🏆

Prof. Lorenz’s contributions to ophthalmology have been recognized with numerous awards and honors. She is a Fellow of the European Board of Ophthalmology (FEBO) and has received prestigious awards such as the Lifetime Achievement Award from the European Paediatric Ophthalmology Society (EPOS) and the Science Award from the Bielschowsky Society. Additionally, she has been elected as a member of esteemed organizations such as the Academia Ophthalmologica Internationalis (AOI) and the European Academy of Ophthalmology (EAO).

Her leadership in the field is also evident from her roles in various international organizations. She served as the President of the International Society of Genetic Eye Diseases and Retinoblastoma (ISGEDR) from 2016 to 2020 and has been an influential figure in the European Vision Institute Clinical Research Network (EVICR.net) and the German Ophthalmological Society (DOG).

Impact and Influence 🌍

Prof. Lorenz’s impact on the field of ophthalmology extends beyond her research and clinical work. She has been a key organizer of international meetings, bringing together experts to discuss the latest advancements in genetic eye diseases, pediatric ophthalmology, and retinal degenerations. Notable events she has organized include the Annual Meeting of the Société de Génétique Ophtalmologique Francophone and the Meeting of the International Society of Genetic Eye Diseases and Retinoblastoma.

Her influence is further reflected in her role as a reviewer for numerous peer-reviewed journals and as a member of editorial boards. She has also been a mentor to countless students and young researchers, shaping the future of ophthalmic genetics through her dedication to teaching and mentorship.

Legacy and Future Contributions 🧬

As Prof. Lorenz continues to contribute to the field through her work at the TransMIT Centre for Translational Ophthalmology, her legacy is one of pioneering research, clinical excellence, and unwavering commitment to advancing the understanding and treatment of genetic eye diseases. Her work has paved the way for future breakthroughs in gene therapy, and her influence will undoubtedly continue to inspire and guide new generations of ophthalmologists and researchers.

In the years to come, Prof. Lorenz’s contributions will likely expand as she remains actively involved in cutting-edge research and international collaborations. Her ongoing projects and the knowledge she imparts to her students and colleagues ensure that her impact on the field will endure for many years, shaping the future of ophthalmology and genetics.

🎓Publication 

Twelve-month Natural History Study of Centrosomal Protein 290 (CEP290)-associated Inherited Retinal Degeneration

  • Authors   :Pierce, E.A., Ashimatey, B.S., Jayasundera, T., … Myers, R., Pennesi, M.E..
  • Journal    :Ophthalmology Science.
  • Year         :2024

Treated Cases of Retinopathy of Prematurity in Germany: 10-Year Data from the Retina.net Retinopathy of Prematurity Registry

  • Authors   :Pfeil, J.M., Barth, T., Lagrèze, W.A., … Völker, M., Hagemann, U.
  • Journal    :Ophthalmology Retina
  • Year         :2024

Comparability of input parameters in the German Retina.net ROP registry and the EU-ROP registry – An exemplary comparison

  • Authors   :Winter, K., Pfeil, J.M., Engmann, H., … Bartmann, I.R., Stahl, A.
  • Journal    :Acta Ophthalmologica,
  • Year         :2024

Single Center Experience with Voretigene Neparvovec Gene Augmentation Therapy in RPE65 Mutation–Associated Inherited Retinal Degeneration in a Clinical Setting

Characterising the refractive error in paediatric patients with congenital stationary night blindness: a multicentre study

Prof Dr. Elaine Leung|Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Prof Dr. Elaine Leung |Pharmacology|Best Researcher Award|

Prof Dr. Elaine Leung at Department of Biomedical Science, Faculty of Health Science, Macau

PROFILE  

scopus

 

Early Academic Pursuits 🎓

Elaine Lai-Han Leung embarked on her academic journey with a strong foundation in biological sciences, obtaining her BSc in Biology and Biochemistry from The Chinese University of Hong Kong in 2001. Her deep interest in biomedical sciences led her to pursue further studies, earning an MPhil in Biochemistry in 2003, followed by a PhD in Physiology in 2006 from the same institution. Her early academic pursuits laid the groundwork for a career marked by significant contributions to biomedical research, particularly in the fields of cancer biology and traditional Chinese medicine.

Professional Endeavors 🧬

Professor Leung’s professional career has been centered at the University of Macau, where she is a prominent figure in the Department of Biomedical Science, Faculty of Health Science. Over the years, she has established herself as a leading researcher, focusing on the intersection of modern biomedical sciences and traditional Chinese medicine. Her work has involved both academic research and collaborations with industry, where she has taken on numerous consultancy projects, contributing to the development of new therapies and drug discoveries.

Contributions and Research Focus 🔬

Professor Leung’s research is primarily focused on cancer biology, with an emphasis on non-small cell lung cancer (NSCLC). She has been the principal investigator (PI) or co-investigator (Co-I) on numerous research projects, many of which are aimed at understanding the mechanisms of drug resistance and the development of novel therapeutic strategies. Her ongoing research includes studies on KRAS resistance mechanisms, the role of gut microbiota in cancer immunomodulation, and the use of traditional Chinese medicine in treating various forms of cancer.

Some of her key projects include:

  • The relationship between KRAS resistance mechanisms and the immune microenvironment: An ongoing project at the University of Macau aimed at uncovering how KRAS mutations affect immune responses in cancer.
  • High-dimensional single-cell analysis of Sotorasib resistance clinical samples: This research seeks to identify new small molecule inhibitors for treating NSCLC.
  • Investigation of the anti-tumor effect of microbial valeric acid in NSCLC: Completed in 2023, this study explored how microbial byproducts can influence tumor immunity.

Accolades and Recognition 🏆

Professor Leung’s contributions to biomedical science have not gone unnoticed. She has been recognized with numerous awards and honors throughout her career, reflecting her standing in the scientific community. Her work has been cited extensively in leading scientific journals, with her citation index reflecting her influence in the fields of cancer biology and traditional Chinese medicine. Her collaboration with Nobel Laureate Erwin Neher on drug research further underscores her prominence in the field.

Impact and Influence 🌍

The impact of Professor Leung’s work extends beyond academia. Her research has significant implications for the development of new cancer therapies, particularly in the context of drug resistance. By bridging the gap between traditional Chinese medicine and modern biomedical research, she has opened new avenues for treatment that could benefit patients worldwide. Her work on gut microbiota and its role in cancer treatment, for instance, is pioneering in its approach and has the potential to revolutionize how cancer is treated.

Legacy and Future Contributions 🌟

As Professor Leung continues her work at the University of Macau, her legacy is already taking shape. She is helping to mentor the next generation of scientists while pushing the boundaries of what is possible in cancer research. Her ongoing projects, including those funded by significant grants, are expected to yield new insights into cancer biology and treatment. Looking ahead, her contributions will likely continue to influence the field of biomedical sciences, particularly in how traditional Chinese medicine is integrated into modern therapeutic strategies.

Research and Innovations 🧪

Completed/Ongoing Research Projects 📊

Professor Leung has completed numerous research projects, with many others ongoing. Her portfolio includes more than a dozen major projects, ranging from small-scale studies to large, collaborative efforts with industry partners. These projects have attracted significant funding, including:

  • Macao Science and Technology Development Fund (2021/2024): Investigating the combinational treatment effects of ginseng polysaccharides with immunotherapy in lung cancer, with a budget of USD 230,769.
  • Zhuhai UM Science and Technology Institute joint lab projects: Ongoing studies on drug resistance and immune microenvironment interactions in cancer, funded at approximately USD 641,000.

Citation Index 📚

Professor Leung’s work is highly regarded in the scientific community, as reflected by her citation index in databases such as Scopus and the Science Citation Index (SCI). Her research articles have been cited extensively, demonstrating the impact and relevance of her work in advancing biomedical science.

Consultancy/Industry Projects 🤝

Beyond academia, Professor Leung has engaged in several industry-sponsored projects, often serving as a consultant. These projects have allowed her to apply her research in practical settings, contributing to the development of new drugs and therapeutic strategies. Notably, she has collaborated with leading pharmaceutical companies like Janssen Pharmaceuticals, where her work on immunophenotyping in lung cancer patients has been highly influential.

Conclusion 🎯

Professor Elaine Lai-Han Leung’s career is a testament to the power of interdisciplinary research and collaboration. Her contributions to cancer biology, her innovative use of traditional Chinese medicine, and her commitment to bridging the gap between research and industry have made her a pivotal figure in her field. As she continues to explore new frontiers in biomedical science, her legacy will undoubtedly be one of lasting impact, shaping the future of cancer treatment and beyond.

🎓Publication 

Tanshinone IIA induces ER stress and JNK activation to inhibit tumor growth and enhance anti-PD-1 immunotherapy in non-small cell lung cancer

  • Authors   :Zhang, Y.-Z., Lai, H.-L., Huang, C., … Wu, Q.-B., Leung, E.L.-H.
  • Journal    :Phytomedicine
  • Year         :2024

Genome engineering of the human gut microbiome

MMP14high macrophages orchestrate progressive pulmonary fibrosis in SR-Ag-induced hypersensitivity pneumonitis

  • Authors   :Peng, D., Li, J., Li, Y., … Yang, P., Li, G.
  • Journal    :Pharmacological Research.
  • Year         :2024

Paris saponin VII reverses resistance to PARP inhibitors by regulating ovarian cancer tumor angiogenesis and glycolysis through the RORα/ECM1/VEGFR2 signaling axis

 

Ms. Nokubonga Zulu|Formulation Science | Best Researcher Award

Published on by Top Pharmaceutical

Ms. Nokubonga ZulFormulation Science |Best Researcher Award|

Ms. Nokubonga Zulu at Johannesburg,South Africa

PROFILE  

scopus

 

Early Academic Pursuits 🎓

Nokubonga Given Zulu’s journey into the field of metallurgy began with a strong academic foundation laid at the University of Johannesburg, one of South Africa’s leading institutions. She pursued a Bachelor of Engineering Technology (BEng Tech Hons) in Extraction Metallurgy, a rigorous program that provided her with the essential knowledge and skills required in the field. Nokubonga demonstrated exceptional dedication and discipline throughout her undergraduate studies, which culminated in her graduation. Her passion for metallurgy, coupled with her strong academic performance, set the stage for her future endeavors.

Following her undergraduate studies, Nokubonga continued to excel academically by enrolling in a Master of Engineering (MEng) degree in Extraction Metallurgy at the same university. She completed this program with distinction, a testament to her hard work and commitment to her field. Her master’s research focused on Biomining, particularly bioflotation, which is a cutting-edge area of study within metallurgical engineering. This research not only broadened her knowledge but also positioned her as a budding expert in the emerging field of biometallurgy.

Professional Endeavors 💼

Nokubonga’s professional journey began while she was still a student. She gained invaluable experience working in various roles at the University of Johannesburg, including as a Mineral Processing Lab Assistant and an Analytical Lab Assistant. These positions allowed her to develop a practical understanding of metallurgical processes and laboratory techniques. She also served as an Academic Tutor, where she helped students grasp complex concepts in process engineering, research methodology, and metallurgical projects. Her role as a Research Assistant further honed her skills in conducting experiments and contributing to academic research, which proved instrumental in her subsequent career.

In 2022, Nokubonga expanded her professional horizons by undertaking a three-month training program as a Trainee Metallurgist at the Kibali Gold Mine, operated by Barrick Gold Corporation in the Democratic Republic of Congo. This experience exposed her to real-world applications of mineral processing, hydrometallurgy, and pyrometallurgy. Working at one of the largest gold mines in Africa, Nokubonga deepened her understanding of the practical challenges faced in the industry, enhancing her critical thinking and problem-solving skills.

Currently, Nokubonga is working as a Graduate Metallurgist at Siyanda Bakgatla Platinum Mine. In this role, she is responsible for plant inspections and tracking process recipes based on day-to-day changes in the plant. This position allows her to apply her academic knowledge in a practical setting, contributing to the optimization and efficiency of metallurgical processes in the platinum mining sector.

Contributions and Research Focus 🔬

Nokubonga’s contributions to the field of metallurgy are noteworthy, particularly in the area of biomining. Her master’s research on bioflotation, a process that uses biological agents to separate valuable minerals from ores, has the potential to revolutionize the field by providing more sustainable and environmentally friendly methods of mineral extraction. This research has not only advanced the academic understanding of biomining but has also positioned Nokubonga as a leader in this niche field.

Her academic contributions include five published research outputs, comprising two journal articles and three conference papers. These publications reflect her deep engagement with the metallurgical community and her commitment to advancing knowledge in her field. Nokubonga’s work is currently under further review, indicating that she continues to push the boundaries of her research, with the potential for more significant contributions in the future.

Accolades and Recognition 🏆

Nokubonga’s academic excellence and professional achievements have not gone unnoticed. Completing her MEng degree with distinction is a significant accolade that underscores her dedication and expertise. While specific awards and recognitions are not detailed in the provided information, her progression from a student to a respected professional in the field is itself a testament to her capabilities and the recognition she has garnered within the academic and professional communities.

Impact and Influence 🌍

Nokubonga Given Zulu’s impact extends beyond her immediate academic and professional achievements. As a South African female in a traditionally male-dominated field, she serves as a role model and inspiration for other young women aspiring to enter the fields of engineering and metallurgy. Her dedication to acquiring knowledge and her pursuit of excellence have positioned her as a leader in her field, with the potential to influence future generations of metallurgists.

Her work in biomining, particularly bioflotation, has the potential to significantly impact the metallurgical industry by promoting more sustainable and environmentally friendly practices. This focus on innovation and sustainability aligns with global trends in mining and metallurgy, further enhancing her influence on the field.

Legacy and Future Contributions 🚀

Looking ahead, Nokubonga’s aspirations include pursuing a Ph.D. with a focus on Geometallurgy and Biometallurgy. This next step in her academic journey will allow her to further specialize in her areas of interest and contribute even more significantly to the field. Her ongoing research and future studies are expected to yield new insights and innovations, further solidifying her legacy as a pioneer in biomining.

Nokubonga’s legacy will be one of dedication, discipline, and a relentless pursuit of knowledge. As she continues to advance in her career, her contributions to both academia and industry are likely to leave a lasting impact on the field of metallurgy. Her journey serves as an inspiration to others, particularly young women, who aspire to make their mark in science and engineering.

Conclusion 🌟

Nokubonga Given Zulu is a shining example of what can be achieved through dedication, discipline, and a passion for learning. Her academic and professional journey reflects a commitment to excellence and a desire to make meaningful contributions to the field of metallurgy. As she continues to pursue her goals, her impact on the field and her legacy as a pioneering female metallurgist are set to grow, inspiring future generations to follow in her footsteps.

🎓Publication 

Optimization of Upper group 2 flotation using Acidithiobacillus ferrooxidans as a modifier

  • Authors   :Zulu, N.G., Thethwayo, B.M., Madiba, M.
  • Journal    :Minerals Engineering
  • Year         :2024

THERMODYNAMIC EFFECTS OF TEMPERATURE DURING ROASTING OF CHROMITE FOR SODIUM CHROMATE SALTS FORMATION

  • Authors   :Mvita, M.J., Zulu, N.G., Thethwayo, B., Makhamisa, S.
  • Journal    :MetalurgijaT
  • Year         :2024

Prof. Fatma YURT|pharmaceuticals | Best Researcher Award

Published on by Top Pharmaceutical

Prof. Fatma YURT |pharmaceuticals|Best Researcher Award|

Prof. Fatma YURT atEge University,Turkey

PROFILE  

scopus

Orcid

Early Academic Pursuits 🎓

Prof. Dr. Fatma Yurt’s journey into the scientific world began at Ege University, one of Turkey’s leading institutions. She completed her undergraduate studies at the Faculty of Science in the Department of Chemistry between 1982 and 1987. Her passion for science and dedication to learning set the stage for her illustrious career in nuclear sciences. Following her bachelor’s degree, she pursued a doctorate at Ege University in the Institute of Nuclear Sciences, specializing in Nuclear Sciences. From 1991 to 1998, she immersed herself in the study of nuclear applications, gaining a deep understanding of the field’s complexities and potential. This period of intense academic focus and research laid a solid foundation for her future contributions to nuclear medicine, radiopharmacy, and related fields.

Professional Endeavors 💼

Prof. Dr. Fatma Yurt’s professional career is marked by her steady rise through the academic ranks at Ege University. She began her career as a Research Assistant in the Nuclear Applications Department of the Institute of Nuclear Sciences, where she served from 1994 to 1997. This role allowed her to engage in cutting-edge research and contribute to the development of nuclear sciences in Turkey.

In 1999, she was promoted to Assistant Professor, and later in the same year, she achieved the rank of Associate Professor. Her commitment to education and research was evident as she continued to mentor students and lead research projects in nuclear applications. By 2007, she had earned the title of Professor, solidifying her position as a leading expert in her field.

Prof. Dr. Yurt’s expertise is not limited to academia; she has also held significant administrative roles. Since 2016, she has served as the Director of the Institute of Nuclear Sciences at Ege University. In this capacity, she has been instrumental in shaping the direction of nuclear research and education in Turkey, overseeing various projects and initiatives that have expanded the institute’s influence both nationally and internationally.

Contributions and Research Focus 🔬

Prof. Dr. Fatma Yurt’s research spans several critical areas within nuclear sciences, with a particular emphasis on nuclear medicine, radiopharmacy, and pharmacology. Her work in these fields has been pivotal in advancing the understanding and application of nuclear techniques in medicine, particularly in diagnosing and treating various diseases.

Her research contributions include the development of novel radiopharmaceuticals, which are essential for diagnosing and treating conditions such as cancer. Prof. Dr. Yurt’s expertise in nuclear chemistry and physical chemistry has enabled her to explore the intricate processes involved in the synthesis and application of these compounds. She has also contributed significantly to the field of health sciences, particularly in the areas of internal medicine and pharmaceutical technology.

With a Scopus publication count of 123 and a Unisis publication count of 296, Prof. Dr. Yurt’s research output is impressive. Her work has been cited over 1,447 times on Scopus, reflecting the impact and relevance of her research. Her H-Index, a measure of both the productivity and citation impact of her publications, stands at 21 on Scopus, further underscoring her influence in the field.

Accolades and Recognition 🏆

Throughout her career, Prof. Dr. Fatma Yurt has received numerous accolades and recognition for her contributions to nuclear sciences and medicine. Her research has been widely acknowledged by her peers, and she has been invited to present her findings at various national and international conferences. Her role as the Director of the Institute of Nuclear Sciences is a testament to her leadership abilities and her dedication to advancing the field of nuclear applications.

Prof. Dr. Yurt’s work has not only advanced scientific understanding but has also had a tangible impact on healthcare. Her contributions to radiopharmacy have been particularly significant, with her research playing a crucial role in the development of new diagnostic and therapeutic methods. Her dedication to her field is further demonstrated by her ongoing involvement in academic mentorship, helping to train the next generation of scientists in nuclear sciences.

Impact and Influence 🌍

Prof. Dr. Yurt’s influence extends beyond her research and academic roles. As a leader in nuclear sciences, she has been instrumental in promoting the importance of nuclear applications in medicine and other fields. Her work has helped to bridge the gap between basic research and practical applications, ensuring that the benefits of nuclear science are realized in clinical settings.

Her leadership at the Institute of Nuclear Sciences has also been pivotal in shaping the research agenda in Turkey, encouraging interdisciplinary collaboration and fostering a culture of innovation. Under her guidance, the institute has strengthened its position as a center of excellence in nuclear research, attracting students and researchers from around the world.

Legacy and Future Contributions 🌟

Prof. Dr. Fatma Yurt’s legacy is one of dedication, innovation, and leadership. Her contributions to nuclear medicine, radiopharmacy, and related fields have had a lasting impact on both the scientific community and the broader healthcare sector. As she continues her work, her influence will undoubtedly grow, inspiring new research and leading to further advancements in nuclear applications.

🎓Publication 

An in vitro evaluation of Hypericum perforatum loaded-chitosan nanoparticle/agarose film as a Wound dressing

Unveiling combat strategies against Candida spp. biofilm structures: Demonstration of photodynamic inactivation with innovative phthalocyanine derivatives

Platinum (II) Schiff Base Complexes and their Effects on the Inhibition of Amyloid β1–42 Aggregation

In Vitro Assessment of 177Lu-Labeled Trastuzumab-Targeted Mesoporous Carbon@Silica Nanostructure for the Treatment of HER2-Positive Breast Cancer

  • Authors   :Tunçel, A., Maschauer, S., Prante, O., Yurt, F.
  • Journal    :Pharmaceuticals
  • Year         :2024

 

Assist Prof Dr. Hossam Hwihy|Immunotherapy |Best Researcher Award

Published on by Top Pharmaceutical

Assist Prof Dr. Hossam Hwihy, Immunotherapy ,Excellence in Innovation Awards

Assist Prof Dr. Hossam Hwihy at Faculty of science Al-Azhar University,Egypt

PROFILE  

scopus

 

Early Academic Pursuits 🎓

Dr. Hossam Mohammed Sayed Hwihy, an Egyptian national born on September 9, 1985, embarked on his academic journey with a deep passion for marine biology and environmental sciences. He completed his B.Sc. in Science with a specialization in Marine Biology from Al-Azhar University, Cairo, in 2007. His early academic pursuits were driven by a keen interest in understanding the complex interactions within marine ecosystems and the impact of human activities on these delicate environments. This foundational knowledge paved the way for his subsequent research in marine pollution and aquaculture, fields in which he would later make significant contributions.

To further his expertise, Dr. Hwihy pursued a Master’s degree in Marine Pollution at Al-Azhar University, graduating in 2018. His research during this period focused on the detrimental effects of pollutants on marine life, particularly how they affect aquatic organisms at the cellular and biochemical levels. His academic journey continued with a Ph.D. in Marine Biology from the same institution, which he completed in 2021. His doctoral research was instrumental in deepening his understanding of marine ecosystems and their responses to environmental stressors.

Professional Endeavors 💼

Dr. Hwihy’s professional career is marked by his dedication to both teaching and research in the field of marine biology and aquaculture. Starting as a Teaching Assistant in Zoology at Al-Azhar University in 2016, he quickly established himself as an enthusiastic and knowledgeable educator. He was involved in teaching a range of courses including Aquaculture, Fish Biology, Marine Pollution, and Seafood Processing to undergraduate students. His teaching philosophy emphasizes the practical application of theoretical knowledge, which has been well-received by his students.

In December 2021, Dr. Hwihy was appointed as a Lecturer and Postdoctoral Researcher at the Faculty of Science and Education, Al-Azhar University, Cairo. In this role, he has continued to contribute to the academic community through his teaching and research. Additionally, he is a founding member of the Al-Azhar Aquaponic Experimental Farm, a pioneering project that integrates aquaculture with hydroponics to create a sustainable food production system. This initiative highlights his commitment to advancing sustainable practices in aquaculture.

Contributions and Research Focus 🔬

Dr. Hwihy’s research contributions span several critical areas within marine biology and aquaculture. His primary research interests include:

  1. Aquaponics Management Systems: Dr. Hwihy has been at the forefront of research into aquaponics, a sustainable farming technique that combines aquaculture (raising fish) with hydroponics (growing plants without soil). His work focuses on optimizing these systems to enhance yield production while minimizing environmental impact.
  2. Nanotechnology in Aquatic Applications: He is actively involved in studying the effects of various nanomaterials on aquatic ecosystems, particularly how these materials can be used to address environmental challenges in aquaculture, such as pollution and disease management.
  3. Climate Change and Molecular Responses: Dr. Hwihy’s research also delves into the impacts of climate change on marine life, particularly at the molecular level. He is investigating how changes in temperature and other environmental factors influence the genetic and physiological responses of marine organisms.
  4. Marine Bioactive Materials and Toxins: His work in this area focuses on the application of marine-derived compounds in managing fish diseases and addressing environmental issues in aquaculture. This research is critical for developing new strategies to enhance the sustainability of fish farming.
  5. Artificial Intelligence in Aquaculture: Dr. Hwihy is exploring the use of artificial intelligence (AI) to improve the management of aquaculture systems. His research aims to develop AI-based tools for monitoring water quality, predicting fish health, and optimizing feeding strategies.

Accolades and Recognition 🏆

Throughout his career, Dr. Hwihy has been recognized for his contributions to marine biology and aquaculture. He has presented his research at numerous conferences and workshops, sharing his insights with the global scientific community. Notable among these is his presentation at the 9th International Conference for Basic Sciences (ISCAZ) in 2017, where he discussed the lethal toxicity of Profenofos and Sesbania sesban on freshwater snails. His work in this area has been published, further establishing his reputation as a researcher of note.

Dr. Hwihy has also been a caller and participant in various workshops, including those focused on aquaponics, nanotechnology, and the application of artificial intelligence in scientific research. His involvement in these events reflects his commitment to continuous learning and knowledge dissemination.

Impact and Influence 🌍

Dr. Hwihy’s work has had a significant impact on the field of aquaculture and marine biology, particularly in Egypt. His research on aquaponics and sustainable aquaculture practices has the potential to revolutionize food production in regions facing water scarcity and environmental degradation. By integrating innovative technologies such as nanotechnology and AI into aquaculture, he is helping to pave the way for more resilient and efficient farming systems.

His contributions extend beyond academia, as he actively engages in community outreach through workshops and seminars aimed at educating the public and industry stakeholders about the benefits of sustainable aquaculture. His role as a founding member of the Al-Azhar Aquaponic Experimental Farm is particularly noteworthy, as it serves as a model for future aquaculture projects in Egypt and beyond.

Legacy and Future Contributions 🚀

As a leading figure in the field of aquaculture and marine biology, Dr. Hwihy’s legacy is one of innovation and sustainability. His research has laid the groundwork for future advancements in sustainable food production, particularly in arid regions where traditional farming methods are less viable. His work in nanotechnology and AI is likely to have far-reaching implications for the future of aquaculture, making it more efficient and environmentally friendly.

🎓Publication 

Threat of heavy metal pollutants and parasites to freshwater fish with special reference to their risk of cancer to humans in Egypt

  • Authors   :Afifi, M.A.M., Radwan, M., Abbas, M.M.M., … Alabssawy, A.N., Khalaf-Allah, H.M.M.
  • Journal    :Aquaculture
  • Year         :2024

Biofloc biosecurity: A revolutionary paradigm in augmenting aquaculture health and resilience against Aeromonas hydrophila

    • Authors :Hwihy, H.M., Zeina, A.F., Abu Husein, M.S., El-Tabakh, M.A.M.
    • Journal   :Aquaculture and Fisheries
    • Year       : 2024

Evaluating of Pea Peels Meal as a Fishmeal alternative in Formulated Diet Ingredients of Oreochromis niloticus

UPLC/ESI/MS profiling of red algae Galaxaura rugosa extracts and its activity against malaria mosquito vector, Anopheles pharoensis, with reference to Danio rerio and Daphnia magna as bioindicators

  • Authors  :El-Tabakh, M.A.M., Elhawary, E.A., Hwihy, H.M., … Bakr, N.A., Shehata, A.Z.I.
  • Journal   :Malaria Journal
  • Year        :   2023

DNA Barcoding and Sensitivity of Dengue Vector Aedes aegypti (Linnaeus, 1762) (Diptera: Culicidae) Aquatic Stages to Different Insecticides with Reference to Non-Target Organisms, Danio rerio and Daphnia magna

Ms. Faezeh Aghajannataj Ahangarkola|Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Ms. Faezeh Aghajannataj Ahangarkola |Drug Delivery Systems|Best Researcher Award|

Ms. Faezeh Aghajannataj Ahangarkola at Babol Noshirvani University of Technology,Iran

PROFILE  

Google scholar

 

Early Academic Pursuits 🎓

Faezeh Aghajannataj began her academic journey with a strong foundation in pure chemistry, earning a Bachelor of Science degree from the University of Mazandaran (UMZ) in Babolsar, Iran, in September 2018. Her undergraduate studies focused on the synthesis of pharmaceutical heterocyclics, particularly through multi-component reactions. Under the guidance of Dr. Robabeh Baharfar, Faezeh’s final project received a stellar grade of 4.0/4.0, demonstrating her early aptitude for research and her keen interest in the intersection of chemistry and pharmaceuticals.

Building on her success at UMZ, Faezeh pursued a Master of Science degree in Biotechnology at the Babol Noshirvani University of Technology (BNUT), Babol, Iran. Her graduate research centered on the development of enteric hard capsules for targeting the small intestine, utilizing innovative materials like Pullulan and Eudragit L-100. This research culminated in a thesis titled “Enteric Hard Capsules for Targeting Small Intestine by Pullulan and Eudragit L-100: Processing, Characterization, and In-vitro Drug Release,” which was awarded a perfect grade of 4.0/4.0 (19/20), reflecting the high quality and significance of her work under the mentorship of Dr. Ghasem Najafpour.

Professional Endeavors 🏢

Faezeh’s professional career is marked by a strong focus on research and development in the pharmaceutical and biotechnology industries. During her time at Iran Gelatin Capsule in Tehran, she played a pivotal role as a member of the R&D team from February 2022 to May 2023. Her work primarily involved researching and formulating pullulan capsules at an industrial scale, a task that required both technical expertise and innovative thinking. Additionally, she contributed to the formulation and evaluation of controlled release systems designed to produce enteric-coated capsules without synthetic materials or external coatings, a project that aligns with the growing demand for more natural and sustainable pharmaceutical solutions.

Faezeh also gained significant experience as a teaching assistant during her academic career. She assisted in courses such as Organic Chemistry Laboratory and Physical Chemistry Laboratory at UMZ, and Advanced Engineering Mathematics at BNUT, showcasing her ability to convey complex scientific concepts to students. Her teaching roles not only enriched her understanding of the subjects but also allowed her to contribute to the academic growth of her peers.

Contributions and Research Focus 🔬

Faezeh’s research interests lie at the crossroads of biotechnology, pharmaceutical sciences, and chemistry. Her master’s thesis on enteric hard capsules represents a significant contribution to the field of drug delivery systems, particularly in the development of targeted delivery mechanisms for the small intestine. This work, which involved detailed processing, characterization, and in-vitro drug release studies, has the potential to impact the way oral medications are formulated and administered, particularly in terms of improving drug efficacy and patient outcomes.

Her research has been recognized through the publication of her work in reputable scientific journals. One notable publication is “Towards a Novel Pullulan and Pullulan-Enteric Hard Capsules: Study of Drug Release and Crucial Capsule Features,” co-authored with Dr. Gh. Najafpour and R. Ramezani. This paper, accessible , highlights the innovative approach Faezeh has taken in her research, contributing valuable knowledge to the field of drug delivery systems.

Accolades and Recognition 🏆

Throughout her academic and professional career, Faezeh has consistently achieved high marks and recognition for her work. Her thesis was awarded a perfect grade, reflecting the high esteem in which her research is held. Additionally, her academic achievements during her bachelor’s and master’s studies are underscored by her strong GPA, which stands at 3.6/4.0 (16.95/20) for her master’s degree, and her consistently high grades in her coursework.

Her work has also been recognized within the academic community through her roles as a teaching assistant, where she earned the trust of her professors to guide and mentor students in complex scientific subjects.

Impact and Influence 🌍

Faezeh’s research on drug delivery systems, particularly her focus on enteric capsules, has the potential to significantly impact the pharmaceutical industry. By developing more effective and targeted drug delivery mechanisms, her work could lead to improved patient outcomes, particularly for those with conditions that require precise delivery of medication to the small intestine.

Her influence extends beyond her research, as her roles as a teaching assistant and R&D member have allowed her to mentor and collaborate with others in the field, spreading her knowledge and fostering innovation in both academic and industrial settings.

Legacy and Future Contributions 🌟

Faezeh Aghajannataj is poised to make lasting contributions to the fields of biotechnology and pharmaceutical sciences. Her innovative approach to drug delivery systems and her commitment to research excellence set her apart as a leading figure in her field. As she continues her career, her work is likely to inspire future research and development in the industry, particularly in the creation of more sustainable and effective pharmaceutical solutions.

🎓Publication 

Ethanol fermentation in an immobilized cell reactor using Saccharomyces cerevisiae

  • Authors   :Ghasem Najafpour, Habibollah Younesi, Ku Syahidah Ku Ismail
  • Journal    :Bioresource technology
  • Year         :2024

Piperine—the bioactive compound of black pepper: from isolation to medicinal formulations

  • Authors   :Leila Gorgani, Maedeh Mohammadi, Ghasem D Najafpour, Maryam Nikzad
  • Journal    :Comprehensive reviews in food science and food safety
  • Year         :2017

High-rate anaerobic digestion of palm oil mill effluent in an upflow anaerobic sludge-fixed film bioreactor

  • Authors   :GD Najafpour, AAL Zinatizadeh, AR Mohamed, M Hasnain Isa, H Nasrollahzadeh
  • Journal    :Process Biochemistry
  • Year         :2006

Treatment of pulp and paper mill wastewater by polyacrylamide (PAM) in polymer induced flocculation

  • Authors   :SS Wong, TT Teng, AL Ahmad, A Zuhairi, G Najafpour
  • Journal    :Journal of hazardous materials
  • Year         :2006

Power generation from organic substrate in batch and continuous flow microbial fuel cell operations

  • Authors   :Mostafa Rahimnejad, Ali Asghar Ghoreyshi, Ghasem Najafpour, Tahereh Jafary
  • Journal    :Applied Energy
  • Year         :2011

Dr. Rajendra Rohokale|Drug Discovery and Development| Best Researcher Award

Published on by Top Pharmaceutical

Dr. Rajendra Rohokale| Drug Discovery and Development ,Best Researcher Award

Dr. Rajendra Rohokale at university of florida,United States

PROFILE  

Orcid

🎓Early Academic Pursuits :

Dr. Rajendra Shankarrao Rohokale embarked on his academic journey with a strong foundation in the sciences, earning his Bachelor of Science in Chemistry from New Arts, Science, and Commerce College, Ahmednagar, affiliated with Savitribai Phule Pune University, Pune, India. His academic pursuit continued with a Master of Science in Organic Chemistry from the same university, where he honed his skills in synthetic organic chemistry, laying the groundwork for his future research endeavors.

During his postgraduate studies, Dr. Rohokale demonstrated a profound interest in organic chemistry, particularly in the areas of synthetic carbohydrate chemistry and glycoscience. His early academic years were marked by a commitment to exploring the complexities of organic compounds, setting the stage for his later achievements in the field.

💼Professional Endeavors :

Dr. Rohokale’s professional journey is characterized by significant contributions to the field of synthetic organic chemistry, with a focus on carbohydrate chemistry, glycoscience, and photoredox catalysis. After completing his Ph.D. in Organic Chemistry from the Department of Chemistry, Savitribai Phule Pune University, he joined the University of Florida as a Research Assistant Professor. Under the mentorship of Prof. Zhongwu Guo, a prominent figure in carbohydrate chemistry, Dr. Rohokale’s work primarily involved the synthesis of complex carbohydrates and their conjugates for therapeutic applications.

Before his tenure at the University of Florida, Dr. Rohokale held a prestigious SERB National Post-doctoral Fellowship at the National Chemical Laboratory, Pune, where he worked under the guidance of Dr. C. V. Ramana. His research during this period focused on the applications of iridium-catalyzed reactions and photoredox catalysis in organic chemistry, contributing to the development of new methodologies in the field.

Dr. Rohokale’s professional experience also includes an international collaboration during the Indigo Program-2012, where he worked on visible light photoredox-catalysis with Prof. Burkhard Koenig at the University of Regensburg, Germany. This collaboration further enriched his research profile, leading to innovative contributions in organic synthesis.

🔬Contributions and Research Focus :

Dr. Rohokale has made significant contributions to the fields of synthetic organic chemistry, carbohydrate chemistry, and photoredox catalysis. His research primarily focuses on developing practical and efficient methods for the chemical and chemoenzymatic synthesis of complex oligosaccharides and glycoconjugates. These include glycoproteins and glycolipids, which are applied to studying related biological and medical problems, such as the functions of glycans and their relationships with diseases.

One of Dr. Rohokale’s notable research contributions is in the area of glycolipids synthesis. His work on glycosylated liposomes for targeted drug delivery and vaccination has potential applications in diagnosing and treating human diseases, including cancer and bacterial infections. His research also extends to the synthesis of biologically relevant molecules, such as GSLs, and their use as probes to explore disease mechanisms.

🏅Accolades and Recognition :

Dr. Rohokale’s academic and research excellence has been recognized through various awards and honors. He was selected for the prestigious SERB National Post-doctoral Fellowship in 2017, acknowledging his potential to contribute to scientific research in India. His selection as a Post-doctoral Fellow at the University of Florida in 2019 further underscores his expertise in carbohydrate chemistry and organic synthesis.

Additionally, Dr. Rohokale has been an active peer reviewer for several high-impact journals, including Chemical Communication and Organic Chemistry Frontiers, published by the Royal Society of Chemistry, and The Journal of Carbohydrate Chemistry, published by the American Chemical Society. His role as a reviewer highlights his standing in the scientific community and his commitment to advancing research in his field.

🌍Impact and Influence :

Dr. Rohokale’s research has had a profound impact on the field of synthetic organic chemistry, particularly in the areas of carbohydrate chemistry and photoredox catalysis. His work on the synthesis of complex carbohydrates and glycoconjugates has implications for medical science, particularly in understanding the role of glycans in diseases and developing new diagnostic tools and therapeutic approaches.

His innovative methodologies in organic synthesis have influenced researchers globally, contributing to the development of new strategies for synthesizing biologically relevant molecules. His collaboration with international institutions, including his work in Germany and the USA, has further extended his influence, making him a respected figure in his field.

🌟Legacy and Future Contributions :

As Dr. Rohokale continues his research at the University of Florida, his legacy in synthetic organic chemistry and carbohydrate research is expected to grow. His contributions to the development of new synthetic methods and their applications in medical science position him as a leading researcher with the potential to make groundbreaking discoveries in the future

🎓Publication 

Diastereoselective 1,3-dipolar intramolecular nitrone olefin cycloaddition (INOC) reaction of a sugar-derived allyl alcohol: Synthesis of functionalized aminocyclopentitols

  • Authors   :Rajendra Rohokale
  • Journal    :
    Carbohydrate Research
  • Year         :2024

Bifunctional glycosphingolipid (GSL) probes to investigate GSL-interacting proteins in cell membranes

  • Authors :Sayan Kundu; Rajendra Rohokale; Chuwei Lin; Sixue Chen; Shayak Biswas; Zhongwu Guo
    • Journal   :
      Journal of Lipid Research
    • Year       : 2024

Monophosphoryl Lipid A-Rhamnose Conjugates as a New Class of Vaccine Adjuvants

  •  Authors  :Rajendra Rohokale; Jiatong Guo; Zhongwu Guo
  • Journal    :
    Journal of Medicinal Chemistry

    Year         :  2024

Development in the Concept of Bacterial Polysaccharide Repeating Unit-Based Antibacterial Conjugate Vaccines

  • Authors  :: Rajendra Rohokale; Zhongwu Guo
  • Journal   :
    ACS Infectious Diseases
  • Year        :   2023

Structural characterization and analysis of different epimers of neutral glycosphingolipid LcGg4 by ion mobility spectrometry-mass spectrometry

  • Authors  :Gao, T.; Lott, A.A.; Huang, F.; Rohokale, R.; Li, Q.; Olivos, H.J.; Chen, S.; Guo, Z.
  • Journal   :
    Analyst
  • Year        :  2022

Prof. Stefano Rivella|Hematology and Gene Therapy| Best Researcher Award

Published on by Top Pharmaceutical

Prof. Stefano Rivella, Hematology and Gene Therapy ,Best Researcher Award

Prof. Stefano Rivella at Children’s Hospital of Philadelphia/University of Pennsylvania,United States

PROFILE  

Orcid

🎓 Early Academic Pursuits :

Stefano Rivella’s academic journey began in Italy, where he pursued his Bachelor of Science (BSc) and Doctor of Philosophy (PhD) at the University of Pavia. His dedication to the field of genetics was evident early on, as he received Italy’s Best University Thesis award from the Italian Genetics Institute (AGI) in 1991. Following his doctoral studies, Dr. Rivella remained at the University of Pavia as a Pre and Doctoral Trainee until 1997. His postdoctoral training took him to the prestigious Memorial Sloan Kettering Cancer Center, where he deepened his expertise in gene therapy and hematology.

🧬 Professional Endeavors :

Dr. Rivella’s professional career is marked by significant contributions to genetic medicine and pediatrics. He began his faculty appointments at Weill Cornell Medical College in 2002, where he served as an Assistant Professor of Genetic Medicine in Pediatrics. His innovative work in gene therapy and pediatrics led to his promotion to Associate Professor in both the Pediatrics and Graduate School divisions by 2008.

In 2015, Dr. Rivella transitioned to the Children’s Hospital of Philadelphia (CHOP), where he became a Professor of Pediatrics. His expertise and impact in the field were further recognized when he was appointed the Kwame Ohene-Frempong Endowed Chair in Pediatric Hematology later that year. Currently, he leads the RNA Gene Therapeutics group at The Penn Institute for RNA Innovation, a role he took on in 2023. This position underscores his leadership in pioneering RNA-based therapies for genetic disorders.

🔬 Contributions and Research Focus :

Dr. Rivella’s research has focused on gene therapy, particularly in the treatment of hemoglobinopathies such as thalassemia. His work has been instrumental in the development of innovative therapeutic strategies, including the approval of the clinical trial “ALS20-101 Lentiviral Gene Therapy for Beta Thalassemia,” which is a significant milestone in the field. This trial, sponsored by the Children’s Hospital of Philadelphia, utilizes the ALS20 vector generated in Dr. Rivella’s laboratory, reflecting his deep involvement in cutting-edge therapeutic development.

His expertise extends beyond academia, as he has served as a consultant for several major pharmaceutical companies, including Novartis, Ionis, and Merck. Dr. Rivella has also played a critical role in designing clinical trials and analyzing data for various drugs, contributing to the advancement of gene therapy and hematology on a global scale.

🏆 Accolades and Recognition :

Dr. Rivella’s contributions to the field have been widely recognized through numerous awards and honors. Early in his career, he received multiple Travel Grant Awards from prestigious organizations such as the International Society of Experimental Hematology (ISEH) and the American Society of Gene & Cell Therapy (ASGCT). Notably, in 2015, he was honored with the Sultan bin Khalifa International Thalassemia Federation Award for Innovative Medical Research, highlighting his impact on thalassemia treatment.

In 2019, Dr. Rivella was awarded the Marcel Simon Award by the International BioIron Society (IBIS), further cementing his status as a leader in the field of iron metabolism and hematology. His most recent accolade, the Outstanding Poster Award in 2024 for his work on lentiviral gene therapy, underscores his ongoing contributions to cutting-edge research in gene therapy.

🌍 Impact and Influence :

Dr. Rivella’s influence extends beyond his immediate research contributions. As a member and leader of various scientific societies, including the American Society of Hematology (ASH) and the International BioIron Society (IBIS), he has helped shape the direction of research and clinical practice in hematology and gene therapy. His role on the Scientific Advisory Boards (SAB) of several biopharmaceutical companies allows him to directly impact the development of new therapies, ensuring that innovative treatments reach patients.

🏅 Legacy and Future Contributions :

Dr. Rivella’s legacy in pediatric hematology and gene therapy is profound. Through his work, countless patients with hemoglobinopathies and other genetic disorders have new hope for effective treatments. His pioneering efforts in RNA gene therapeutics promise to revolutionize the field, offering novel approaches to previously intractable conditions.

As he continues his research and leadership at CHOP and The Penn Institute for RNA Innovation, Dr. Rivella’s future contributions are poised to further advance the field of gene therapy. His commitment to education, research, and clinical excellence ensures that his legacy will endure, inspiring future generations of scientists and clinicians dedicated to improving the lives of patients with genetic disorders.

🎓Publication 

Iron restriction in sickle cell disease: When less is more

  • Authors   :Oswaldo L. Castro; Lucia De Franceschi; Tomas Ganz; Julie Kanter; Gregory J. Kato; Sant‐Rayn Pasricha; Stefano Rivella; John C. Wood
  • Journal    :American Journal of Hematology
  • Year         :2024

Optimizing lentiviral genomic integrations to cure beta-thalassemia: The least required for success?

    • Authors :Stefano Rivella
    • Journal   :
      Molecular Therapy – Methods & Clinical Development
    • Year       : 2024

Elevated CDKN1A (P21) mediates β-thalassemia erythroid apoptosis, but its loss does not improve β-thalassemic erythropoiesis

  • Authors  :Raymond Liang; Miao Lin; Vijay Menon; Jiajing Qiu; Anagha Menon; Laura Breda; Tasleem Arif; Stefano Rivella; Saghi Ghaffari
  • Journal    :Blood Advances
  • Year         :  2023.

DNA binding to TLR9 expressed by red blood cells promotes innate immune activation and anemia

  • Authors  :L. K. Metthew Lam; Sophia Murphy; Dimitra Kokkinaki; Alessandro Venosa; Scott Sherrill-Mix; Carla Casu; Stefano Rivella; Aaron Weiner; Jeongho Park; Sunny Shin et al
  • Journal   :
    Science Translational Medicine
  • Year        :   2021

Red Blood Cells Function as DNA Sensors

  • Authors  :Metthew Lam; Sophia Murphy; Dimitra Kokkinaki; Alessandro Venosa; Scott Sherrill-Mix; Carla Casu; Stefano Rivella; Aaron Weiner; Jeongho Park; Sunny Shin et al.
  • Journal   :Preprint
  • Year        :  2021

Mrs. Anke van Engen|Pharmaceutical Policy and Regulation | Best Researcher Award

Published on by Top Pharmaceutical

Mrs. Anke van Engen |Pharmaceutical Policy and Regulation|Best Researcher Award|

Mrs. Anke van Engen atIQVIA,Netherlands

PROFILE  

Scopus

 

Early Academic Pursuits 🎓

Anke van Engen’s academic journey began at the University of Leiden in the Netherlands, where she pursued a Master of Science (MSc) degree in Chemistry, specializing in Bio-organic Chemistry. Her passion for understanding the intricate mechanisms of chemistry and its application to life sciences laid a strong foundation for her future endeavors. Her academic pursuits were not confined to the classroom; she also completed an internship in biochemistry at the Institute of Fundamental Sciences, Massey University in New Zealand, in 1999. This experience provided her with hands-on exposure to research and innovative scientific methodologies, marking the beginning of her profound interest in health economics and outcomes research.

Professional Endeavors 🏢

Anke’s professional journey began in 2000 as a PR Assistant at KPN Research, where she gained experience in communications and public relations within the research and innovation sector. However, her true calling was in consultancy, which she pursued by joining Quintiles Consulting in 2001 as an Associate Consultant. Her initial work focused on health economics (HE) modeling, including decision tree and Markov models, patient chart analyses, and market scans. Anke quickly progressed within the company, taking on roles with increasing responsibility, such as Consultant, Senior Consultant, and eventually Consulting Director.

During her time at Quintiles, Anke developed a unique understanding of innovative technologies for supporting clinical and health outcomes studies. She became instrumental in the development of health economic models used in key submissions to organizations like NICE (National Institute for Health and Care Excellence) and SMC (Scottish Medicines Consortium). Her expertise in market access (MA) strategy, value argument development, and health economics led to her appointment as the Principal at Quintiles Advisory Services, where she led the development of the HTA Accelerator—an online platform that became the flagship product for market access solutions.

In 2017, Anke transitioned to IQVIA, where she continued her trajectory of success. She took on roles such as Senior Principal and Managing Principal, leading international teams and developing EMEA-specific offerings in health economics and market access. Her leadership and strategic insights have been crucial in shaping the payer evidence solutions landscape across the EMEA region.

Contributions and Research Focus 🧠

Anke van Engen’s contributions to the field of health economics, outcomes research, and market access are substantial. Her work has focused on developing integrated solutions that provide strategic insights for life sciences companies, enabling them to navigate the complex landscape of health technology assessments (HTAs) and market access requirements. Her leadership in the development of the HTA Accelerator platform has been particularly impactful, offering a comprehensive solution for gathering payer insights and facilitating launch readiness.

Anke’s research focus extends beyond practical applications to thought leadership in the industry. She has consistently contributed to the development of innovative methodologies and best practices in health economics and market access, helping to advance the field and improve the commercial success of pharmaceutical products.

Accolades and Recognition 🏆

Throughout her career, Anke has received numerous awards and accolades that reflect her expertise and influence in the field. Notable among these are the ISPOR Best Podium and Poster Awards, which she received in 2012 and 2011, respectively, for her work on understanding the complexities of HTA networks and the stakeholder decision-making process in the UK. Her contributions have been recognized at various international conferences, where her issue panels have consistently ranked among the top-attended sessions. In 2014, she won the Sharktank contest for best innovation, securing investment for the HTA Accelerator platform—a testament to her innovative thinking and ability to drive impactful solutions.

Impact and Influence 🌍

Anke van Engen is widely respected by her colleagues, clients, and the broader industry for her deep expertise, strategic vision, and collaborative approach. Her ability to build long-lasting partnerships with clients and deliver consistent results has made her a trusted advisor in the life sciences sector. She has played a pivotal role in shaping the market access landscape in Europe and beyond, influencing the way companies approach payer evidence strategies.

🎓Publication 

Use of External Comparators for Health Technology Assessment Submissions Based on Single-Arm Trials

  • Authors   :Patel, D., Grimson, F., Mihaylova, E., … van Engen, A., Kim, J
  • Journal    :Value in Health
  • Year         :2021

 

Prof Dr. THAWATCHAI PHAECHAMUD| Drug Delivery Systems | Best Researcher Award-1299

Published on by Top Pharmaceutical

Prof Dr. THAWATCHAI PHAECHAMUD, Drug Delivery Systems ,Best Researcher Award

Prof Dr. THAWATCHAI PHAECHAMUD atSilpakorn University,Thailand

PROFILE  

Google scholar 

Scopus

Orcid

Early Academic Pursuits 🎓

Thawatchai Phaechamud, Mr., embarked on his academic journey at the Faculty of Pharmacy, Silpakorn University, Thailand, where he earned his Bachelor of Pharmacy (B.Pharm) degree in 1991. Demonstrating a strong interest in pharmaceutical sciences from an early stage, he advanced his studies at the Faculty of Pharmaceutical Sciences, Chulalongkorn University. There, he completed his Master of Science (M.Sc.) in Manufacturing Pharmacy in 1995, with a thesis focused on the “Effect of variables in chitosan film on propranolol hydrochloride coated tablets.” His academic journey culminated in a Ph.D. in Pharmaceutics from the same institution in 1999. His doctoral thesis, titled “Film-coating of chitosan onto propranolol hydrochloride tablet: Approach to fast and extended drug release,” laid the foundation for his future contributions to the field of pharmaceutics, particularly in drug delivery systems.

Professional Endeavors 🧑‍🏫

Mr. Phaechamud began his professional career as a Lecturer at the Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, from 1991 to 1993. During this period, he honed his teaching skills and laid the groundwork for a lifelong commitment to academia. From 1994 to 1996, he served as a research student at the Faculty of Pharmaceutical Sciences, Chulalongkorn University, further deepening his research capabilities. His academic prowess earned him a position as a Visiting Scientist at the Department of Pharmaceutics, Toyama Medical & Pharmaceutical University in Japan from November 1997 to January 1998.

Upon completing his Ph.D., Mr. Phaechamud returned to Silpakorn University, where he served as an Assistant Professor from 1999 to 2003 in the Department of Pharmaceutical Technology. His dedication to teaching and research led to his promotion to Associate Professor in 2004, a position he has held ever since. His roles have expanded over the years, including serving as the Head of the Department of Pharmaceutical Technology from 2008 to 2009 and Chairman of the Pharmaceutical Engineering Doctoral Program from 2017 to 2018. Since 2018, Mr. Phaechamud has held the esteemed title of Professor in the Department of Industrial Pharmacy, Faculty of Pharmacy at Silpakorn University.

Contributions and Research Focus 🔬

Mr. Phaechamud’s research interests are diverse, focusing on various aspects of pharmaceutical sciences. His work primarily revolves around controlled drug delivery systems, in situ forming gels, matrix film and tablet characterizations, herbal preparation and development, pharmaceutical film coating, and pharmaceutical excipient characterization. He has made significant contributions to the development of controlled drug delivery systems, a field that aims to enhance the efficacy and safety of medications by controlling the rate, time, and place of drug release.

His expertise in polymeric film characterization and pharmaceutical excipient characterization has been instrumental in advancing the understanding of drug delivery mechanisms. His work on in situ forming gels and matrix films has paved the way for innovative drug delivery solutions, particularly in the treatment of chronic conditions where sustained drug release is crucial.

Accolades and Recognition 🏆

Throughout his illustrious career, Mr. Phaechamud has received numerous accolades and recognition for his contributions to pharmaceutical sciences. In June 2006, he was honored as a TRF Research Scholar by The Thailand Research Fund, a prestigious recognition of his research excellence. His leadership in the “Development of standard extract of SC for pharmaceutical and cosmetic applications” research program at Silpakorn University in 2008-2009 further solidified his reputation as a leading researcher in his field.

His publications in high-impact journals reflect the quality and impact of his research. Notable publications include works in the International Journal of Biological Macromolecules, Polymers, AAPS PharmSciTech, and Pharmaceutics, where his research on topics such as transdermal and periodontal pocket drug delivery systems, in situ gels, and solvent-removal zein-based in situ gels has garnered significant attention.

Impact and Influence 🌍

Mr. Phaechamud’s research has had a profound impact on the field of pharmaceutics, particularly in the area of drug delivery systems. His work on controlled drug delivery systems and in situ forming gels has influenced the development of new therapeutic approaches that improve patient outcomes by ensuring more effective and targeted drug delivery.

His influence extends beyond research; as an educator, he has mentored countless students, many of whom have gone on to become leaders in the pharmaceutical industry and academia. His teachings on modified release solid dosage forms, controlled drug delivery systems, and polymer degradation have been instrumental in shaping the next generation of pharmaceutical scientists.

Legacy and Future Contributions 🌟

Mr. Phaechamud’s legacy is one of innovation, dedication, and excellence in the field of pharmaceutical sciences. His work has not only advanced the understanding of drug delivery mechanisms but also paved the way for new therapeutic solutions that have the potential to improve the lives of millions of patients worldwide.

As he continues his work at Silpakorn University, Mr. Phaechamud is

🎓Publication 

Moist heat treatment on physicochemical change of chitosan salt films

  • Authors   :Garnpimol C Ritthidej, Thawatchai Phaechamud, Tamotsu Koizumi
  • Journal    :International journal of pharmaceutics
  • Year         :2002

Gentamicin sulfate-loaded porous natural rubber films for wound dressing

    • Authors :Thawatchai Phaechamud, Pongsathorn Issarayungyuen, Wiwat Pichayakorn
    • Journal   :International journal of biological macromolecules
    • Year       : 2016

Sustained-release from layered matrix system comprising chitosan and xanthan gum

  • Authors  :Thawatchai Phaechamud, Garnpimol C Ritthidej
  • Journal    :Drug development and industrial pharmacy
  • Year         :  2007

The study of antioxidant capacity in various parts of Areca catechu L.

  • Authors  :Penpun Wetwitayaklung, Thawatchai Phaechamud, Chutima Limmatvapirat, Sindhchai Keokitichai
  • Journal   :Naresuan University Journal: Science and Technology (NUJST)
  • Year        :   2006

Antibacterial activity and drug release of chitosan sponge containing doxycycline hyclate

  • Authors  :Thawatchai Phaechamud, Juree Charoenteeraboon
  • Journal   :Aaps PharmSciTech
  • Year        :  2008